论文部分内容阅读
新修订的《中华人民共和国药品管理法》 (以下简称新修订《药品管理法》) ,于 2 0 0 1年 2月 2 8日经九届全国人大常委会第 2 0次会议审议通过 ,江泽民主席签发了第 4 5号主席令予以公布 ,并将于 2 0 0 1年1 2月 1日起施行。这是我国社会经济生活中的一件大事 ,是我国法制建设的又一重大成果 ,对我们医药行业和药品监管系统来说 ,更是具有里程碑式的意义。在此 ,我们编发了广东省“粤药管办 [2 0 0 1 ]2 39号文件传达的 3篇领导讲话及相关文章 ,旨在让人民群众充分了解《药品管理法》修订的重要意义 ,认识新法的重要特点 ,更加规范药品研究、生产、经营、使用和管理的各个环节的行为 ,依法治药 ,保障人民用药安全有效 ,加快我国医药行业的现代化进程。
The newly revised Drug Administration Law of the People’s Republic of China (hereinafter referred to as the newly revised Drug Administration Law) was reviewed and approved by the 20th meeting of the Ninth National People’s Congress on February 28, 2001, and Jiang Zemin The Chairman issued Order No. 45 to be published and will come into effect on February 1, 2001. This is a major event in our country’s social and economic life and another major achievement in the legal construction in our country. It is even more of landmark significance to our pharmaceutical industry and the drug regulatory system. Here, we compiled 3 leading speeches and related articles delivered by the Guangdong Provincial Administration for Drug Control over Drugs [2 0 0] 2 39, aiming at making the people fully understand the significance of the revision of the Drug Administration Law, Recognize the important features of the new law, regulate the behavior of all aspects of research, production, operation, use and management of pharmaceuticals, administer medicine in accordance with the law, ensure people’s medication safety and effectiveness, and speed up the modernization of China’s pharmaceutical industry.